CD4 and myeloid sarcoma: In MS, where brain lesions are dominated by clonally-expanded CD8+ T cells and CD20+ B cell infiltrates (44, 45), it is possible that OM-peptides would suppress both peptide-specific CD4+ and CD8+ T cells by bystander suppression from the alternatively-activated APC.